Koers Paxman AB (publ) Nasdaq Stockholm
Aandelen
SE0009806284
Medische apparatuur, benodigdheden & distributie
Omzet 2024 * | 292 mln. 27,8 mln. 26 mln. | Omzet 2025 * | 401 mln. 38,18 mln. 35,7 mln. | Marktkapitalisatie | 856 mln. 81,47 mln. 76,17 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 34 mln. 3,24 mln. 3,03 mln. | Nettowinst (verlies) 2025 * | 84 mln. 8 mln. 7,48 mln. | EV/omzet 2024 * | 2,79 x |
Nettoliquiditeiten 2024 * | 42 mln. 4 mln. 3,74 mln. | Nettoliquiditeiten 2025 * | 97 mln. 9,24 mln. 8,64 mln. | EV/omzet 2025 * | 1,89 x |
K/w-verhouding 2024 * |
25
x | K/w-verhouding 2025 * |
10,2
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 35,76% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Richard Paxman
CEO | Chief Executive Officer | 41 | 20-12-16 |
Director of Finance/CFO | 44 | 01-03-20 | |
Emma Thornhill
DFI | Director of Finance/CFO | 39 | 01-01-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Björn Littorin
BRD | Director/Board Member | 77 | 01-12-16 |
Chairman | 70 | 01-12-16 | |
Maria Bech
BRD | Director/Board Member | 56 | 20-12-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,95% | 184 mld. | |
-0,90% | 105 mld. | |
-2,27% | 68,87 mld. | |
+15,24% | 46,61 mld. | |
-6,00% | 46,39 mld. | |
+5,36% | 40,74 mld. | |
+20,65% | 31,26 mld. | |
-5,50% | 24,24 mld. | |
+11,60% | 24 mld. |